T Cell News and Research

Latest T Cell News and Research

SARS-CoV-2-specific T cells are broader after vaccination than after infection

SARS-CoV-2-specific T cells are broader after vaccination than after infection

1 May 2022
Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

1 May 2022
Novel method could bring life-saving benefits of CAR T-cell therapy to patients with acute myeloid leukemia

Novel method could bring life-saving benefits of CAR T-cell therapy to patients with acute myeloid leukemia

28 Apr 2022
Exploring oncolytic viral therapeutics and immunotherapies derived from DNA and RNA

Exploring oncolytic viral therapeutics and immunotherapies derived from DNA and RNA

28 Apr 2022
Researchers demonstrate the efficiency of T-cell immune response against the Omicron variant

Researchers demonstrate the efficiency of T-cell immune response against the Omicron variant

28 Apr 2022
Combination therapy shows promise for treating triple-negative breast cancer

Combination therapy shows promise for treating triple-negative breast cancer

27 Apr 2022
How severity and progression of COVID-19 affect cytokine profiles in pregnant women

How severity and progression of COVID-19 affect cytokine profiles in pregnant women

27 Apr 2022
Superior T-cell immunity in COVID vaccinated

Superior T-cell immunity in COVID vaccinated

27 Apr 2022
Roswell Park experts to share latest advances in the treatment of blood-related cancers

Roswell Park experts to share latest advances in the treatment of blood-related cancers

26 Apr 2022
mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

26 Apr 2022
Scientists show how T cells may help protect against severe COVID

Scientists show how T cells may help protect against severe COVID

25 Apr 2022
COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

25 Apr 2022
The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

25 Apr 2022
Detection of prior SARS-CoV-2 infection by T-cell receptor sequencing

Detection of prior SARS-CoV-2 infection by T-cell receptor sequencing

24 Apr 2022
Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

21 Apr 2022
RNA splicing abnormalities in COVID-19 patients

RNA splicing abnormalities in COVID-19 patients

20 Apr 2022
Study investigates co-metabolism during SARS-CoV-2 infection

Study investigates co-metabolism during SARS-CoV-2 infection

20 Apr 2022
CAR T-Cell Therapy: The Future of Cancer and HIV Treatment?

CAR T-Cell Therapy: The Future of Cancer and HIV Treatment?

20 Apr 2022
Research sheds new light on how the body's immune system deals with malaria

Research sheds new light on how the body's immune system deals with malaria

19 Apr 2022
Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

18 Apr 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback